Trial Profile
Comparison of insulin detemir and insulin glargine on glucose variability in type 1 and type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Oct 2011
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Sep 2011 Actual end date Jun 2009 added as reported by University Hospital Medical Information Network - Japan record.
- 30 Sep 2011 Status changed from discontinued to completed as reported by University Hospital Medical Information Network - Japan record.
- 11 Dec 2008 New trial record.